Global Antibacterial Drugs Market
- POSTED ON Friday, July 23, 2021
Global Antibacterial Drugs Market was valued at US$ 26.4 Bn in 2019 and is expected to reach US$ 34.2 Bn by 2026, at a CAGR of 3.29% during a forecast period.
The report includes an analysis of the impact of COVID-19 lockdown on the revenue of market leaders, followers, and disruptors. Since the lockdown was implemented differently in various regions and countries; the impact of the same is also seen differently by regions and segments. The report has covered the current short-term and long-term impact on the market, and it would help the decision-makers to prepare the outline and strategies for companies by region.
To know about the Research Methodology:-Request Free Sample Report
Growth in the old population, rising demand for efficient & affordable antibacterial drugs, and an increasing number of multi-drug resistant bacterial strains are some of the key factors that are driving the global antibacterial drugs market.
The high prevalence of infectious diseases, increased research and development activities, product differentiation through various methods, and rise in government support are boosting the growth of the market. The growing number of product approval and subsequent launch of the products is the main factor expected to boost the growth of the market over the forecast period.
Reduced time for action and fewer side effects are projected to offer a good opportunity for the growth of the antibacterial drugs market. However, the rise in drug-resistant species, the launch of generic drugs, and patent expiry are limiting the growth of the market.
The retail pharmacies segment accounts for a major revenue share of the global antibacterial drugs market owing to providing advice about health issues, symptoms & medications responding to customer inquiries, recruiting, training & managing staff, and treating prescriptions & dispensing medication.
Penicillin is a group of antibiotics, which contain penicillin G, penicillin V, procaine penicillin, and benzathine penicillin. Penicillin antibiotics are among the first medications to be in effect against many bacterial infections caused by staphylococci and streptococci.
The cephalosporins are a class of β-lactam antibiotics, which are originally derived from the fungus Acremonium. Cephalosporin drugs are used to treat bacterial infections including ear & skin infections, pneumonia, kidney & bone infections, sexually transmitted infections such as gonorrhea, and strep throat & other throat infections.
Cell wall biosynthesis inhibitors (CBIs) is one of the most effective mechanism of antibiotics and the most extensively used class of antibiotics. However, this mechanism of antibiotics is not received impunity from resistance development.
North America is leading the global antibacterial drugs market in terms of revenue owing to the presence of significant market players in the region. Europe accounts for the second-largest revenue share in the global antibacterial drugs market, followed by Asia Pacific, South America, and the Middle East & Africa respectively. The Asia Pacific is estimated to register comparatively faster growth in terms of revenue during the forecast period owing to the increasing number of healthcare infrastructure and the growing prevalence of bacterial infections.
Key players operating in the global antibacterial drugs market are Pfizer, Inc., Merck & Co., Inc. Johnson & Johnson, and GlaxoSmithKline plc.
The report covers a comprehensive study of major market drivers, restraints, opportunities, challenges, PESTEL, Porters, SWOT, and technological forecasting in the market.
For More Information Visit :https://www.maximizemarketresearch.com/market-report/global-antibacterial-drugs-market/23877/
The Scope of the Global Antibacterial Drugs Market: Inquire before buying
Global Antibacterial Drugs Market, by Drug Class:
• Penicillins• Cephalosporins• Quinolone• Aminoglycosides• Monobactams• Carbapenems• Macrolides• Other Drug ClassGlobal Antibacterial Drugs Market, by Drug Mechanism:
• Cell Wall Synthesis inhibitors• Protein Synthesis inhibitors• Nucleic Acid inhibitors• Folic Acid synthesis inhibitors• Mycolic Acid synthesis inhibitorsGlobal Antibacterial Drugs Market, by Route of Administration:
• Oral• Topical• Parenteral• Other Route of AdministrationGlobal Antibacterial Drugs Market, by Distribution Channel:
• Hospital Pharmacies• Drug Stores & Retail Pharmacies• Online SalesGlobal Antibacterial Drugs Market, by Region:
• North America• Europe• Asia-Pacific• South America• Middle East & AfricaKey Player Operating in the Global Antibacterial Drugs Market:
• Pfizer, Inc.• Merck & Co., Inc.• GlaxoSmithKline plc.• Novartis AG• Eli Lilly & Company• Johnson & Johnson• Sanofi• AstraZeneca plc.• Bayer AG• Abbott Laboratories• Daiichi Sankyo Company• Takeda Pharmaceutical Company Ltd• Bristol Myers Squibb Company• Allergen Plc.
This Report Is Submitted By : Maximize Market Research Company
Customization of the report:
Maximize Market Research provides free personalized of reports as per your demand. This report can be personalized to meet your requirements. Get in touch with us and our sales team will guarantee provide you to get a report that suits your necessities.
About Maximize Market Research:
Maximize Market Research provides B2B and B2C research on 20,000 high growth emerging opportunities & technologies as well as threats to the companies across the Healthcare, Pharmaceuticals, Electronics & Communications, Internet of Things, Food and Beverages, Aerospace and Defense and other manufacturing sectors.